{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:06:22Z","timestamp":1784189182793,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006390","name":"University of Lausanne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Atrial fibrillation (AF) is associated with a heightened risk of thromboembolic events (TE). Whether severe mitral regurgitation (MR) has a protective effect against thrombus formation in AF remains unclear. We aimed to evaluate the impact of MR severity on thromboembolic risk in patients with AF. This systematic review with meta-analysis included data from eight studies, from 1998 to 2022. All studies reported the prevalence of TE according to MR severity, in patients with non-valvular AF, defined as the absence of prosthetic\/repaired mitral valve or moderate or more severe mitral stenosis. TE was defined as stroke, transient ischemic attack, another arterial embolic event, or presence of thrombus in the left atrium. Eight studies with a total of 21,821 patients (54% male, mean age 70\u2009\u00b1\u200911 years) were identified. The overall prevalence of TE was 6.0%. No significant difference was observed in the prevalence of TE based on MR severity (no or mild MR: 5.9%, moderate or more severe MR: 6.8%, odds ratio: 1.11, 95% confidence interval: 0.77\u20131.73,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.64). When specifically examining studies that exclusively reported either embolic or thrombotic events, there was no statistically significant difference in the incidence rates of events observed across the different categories of MR severity. Our analysis found no significant association between MR severity and the risk for TE, in patients with non-valvular AF. This suggests that MR may not be a determining factor for thromboembolic risk in this population.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Clinical Trial registration (PROSPERO)<\/jats:bold>\n                    CRD42024504403.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>\n                  <jats:p>AF: Atrial fibrillation, MR: Mitral regurgitation<\/jats:p>","DOI":"10.1007\/s10554-025-03487-7","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T07:00:47Z","timestamp":1754636447000},"page":"1247-1256","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of mitral regurgitation severity on thromboembolic risk in atrial fibrillation: a comprehensive systematic review and meta-analysis"],"prefix":"10.1007","volume":"42","author":[{"given":"Adil","family":"Salihu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Tzimas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Monney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccolo","family":"Maurizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Skalidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Arangalage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Auberson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hugelshofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Teres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Antiochos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"issue":"5","key":"3487_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G et al (2021) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for Cardio-Thoracic surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European society of cardiology (ESC) developed with the special contribution of the European heart rhythm association (EHRA) of the ESC. Eur Heart J 42(5):373\u2013498","journal-title":"Eur Heart J"},{"issue":"2","key":"3487_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jacc.2019.11.013","volume":"75","author":"F Bisbal","year":"2020","unstructured":"Bisbal F et al (2020) Atrial failure as a clinical entity: JACC review topic of the week. J Am Coll Cardiol 75(2):222\u2013232","journal-title":"J Am Coll Cardiol"},{"key":"3487_CR3","unstructured":"Van Gelder IC et al (2024) ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal, 2024. 45(36): pp. 3314\u20133414"},{"issue":"9","key":"3487_CR4","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0002-9149(98)00556-6","volume":"82","author":"M Ozkan","year":"1998","unstructured":"Ozkan M et al (1998) Predictors of left atrial thrombus and spontaneous echo contrast in rheumatic valve disease before and after mitral valve replacement. Am J Cardiol 82(9):1066\u20131070","journal-title":"Am J Cardiol"},{"issue":"10","key":"3487_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/clc.4960171007","volume":"17","author":"C Wanishsawad","year":"1994","unstructured":"Wanishsawad C et al (1994) Spontaneous echo contrast on transthoracic echocardiography and left atrial thrombus in rheumatic mitral valve disease patients: a clinicopathologic study. Clin Cardiol 17(10):547\u2013551","journal-title":"Clin Cardiol"},{"issue":"11 Pt 2","key":"3487_CR6","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1111\/j.1540-8159.2000.tb07039.x","volume":"23","author":"A Kranidis","year":"2000","unstructured":"Kranidis A et al (2000) Mitral regurgitation protects from left atrial thrombogenesis in patients with mitral valve disease and atrial fibrillation. Pacing Clin Electrophysiol 23(11 Pt 2):1863\u20131866","journal-title":"Pacing Clin Electrophysiol"},{"issue":"4","key":"3487_CR7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ejcts\/ezab389","volume":"60","author":"A Vahanian","year":"2021","unstructured":"Vahanian A et al (2021) 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg 60(4):727\u2013800","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"3487_CR8","first-page":"e35","volume":"143","author":"CM Otto","year":"2020","unstructured":"Otto CM et al (2020) 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: A report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines. Circulation 143(5):e35\u2013e71","journal-title":"Circulation"},{"key":"3487_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP et al (2011) The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928","journal-title":"BMJ"},{"issue":"3","key":"3487_CR10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0002-8703(98)70231-5","volume":"136","author":"H Nakagami","year":"1998","unstructured":"Nakagami H et al (1998) Mitral regurgitation reduces the risk of stroke in patients with nonrheumatic atrial fibrillation. Am Heart J 136(3):528\u2013532","journal-title":"Am Heart J"},{"issue":"3","key":"3487_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0167-5273(99)00208-9","volume":"72","author":"Y Miyasaka","year":"2000","unstructured":"Miyasaka Y et al (2000) Mild mitral regurgitation was associated with increased prevalence of thromboembolic events in patients with nonrheumatic atrial fibrillation. Int J Cardiol 72(3):229\u2013233","journal-title":"Int J Cardiol"},{"issue":"5","key":"3487_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.echo.2011.02.010","volume":"24","author":"S Ayirala","year":"2011","unstructured":"Ayirala S et al (2011) Echocardiographic predictors of left atrial appendage thrombus formation. J Am Soc Echocardiogr 24(5):499\u2013505","journal-title":"J Am Soc Echocardiogr"},{"issue":"10","key":"3487_CR13","doi-asserted-by":"publisher","first-page":"660","DOI":"10.2459\/JCM.0000000000000838","volume":"20","author":"A Cresti","year":"2019","unstructured":"Cresti A et al (2019) Does mitral regurgitation reduce the risks of thrombosis in atrial fibrillation and flutter? J Cardiovasc Med (Hagerstown) 20(10):660\u2013666","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"3487_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijcard.2020.04.039","volume":"314","author":"L Chen","year":"2020","unstructured":"Chen L et al (2020) A new risk model of assessing left atrial appendage thrombus in patients with atrial fibrillation - using multiple clinical and transesophageal echocardiography parameters. Int J Cardiol 314:60\u201363","journal-title":"Int J Cardiol"},{"key":"3487_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.amjcard.2021.01.006","volume":"145","author":"SL Van Laer","year":"2021","unstructured":"Van Laer SL et al (2021) Effect of mitral regurgitation on thrombotic risk in patients with nonrheumatic atrial fibrillation: a new CHA(2)DS(2)-VASc score risk modifier?? Am J Cardiol 145:69\u201376","journal-title":"Am J Cardiol"},{"issue":"1","key":"3487_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/heartjnl-2020-317659","volume":"108","author":"R Melduni","year":"2022","unstructured":"Melduni R et al (2022) Risk of left atrial appendage thrombus and stroke in patients with atrial fibrillation and mitral regurgitation. Heart 108(1):29\u201336","journal-title":"Heart"},{"issue":"8\u20139","key":"3487_CR17","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.acvd.2022.05.006","volume":"115","author":"S Raposeiras-Roubin","year":"2022","unstructured":"Raposeiras-Roubin S et al (2022) Effect of mitral regurgitation on stroke risk in patients with non-rheumatic atrial fibrillation. Arch Cardiovasc Dis 115(8\u20139):448\u2013456","journal-title":"Arch Cardiovasc Dis"},{"issue":"3","key":"3487_CR18","volume":"12","author":"A Bisson","year":"2019","unstructured":"Bisson A et al (2019) Stroke and thromboembolism in patients with atrial fibrillation and mitral regurgitation. Circulation: Arrhythmia and Electrophysiology 12(3):e006990","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"issue":"28","key":"3487_CR19","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1093\/eurheartj\/ehv163","volume":"36","author":"R Philippart","year":"2015","unstructured":"Philippart R et al (2015) Prognostic value of CHA2DS2-VASc score in patients with \u2018non-valvular atrial fibrillation\u2019 and valvular heart disease: the Loire Valley atrial fibrillation project. Eur Heart J 36(28):1822\u20131830","journal-title":"Eur Heart J"},{"issue":"18","key":"3487_CR20","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1093\/eurheartj\/ehm356","volume":"28","author":"S Habara","year":"2007","unstructured":"Habara S et al (2007) Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J 28(18):2217\u20132222","journal-title":"Eur Heart J"},{"issue":"2","key":"3487_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation. Chest 137(2):263\u2013272","journal-title":"Chest"},{"key":"3487_CR22","doi-asserted-by":"crossref","unstructured":"Fukada J et al (1998) Is atrial fibrillation resulting from rheumatic mitral valve disease a proper indication for the maze procedure? Ann Thorac Surg, 65(6): pp. 1566-9; discussion 1569-70","DOI":"10.1016\/S0003-4975(98)00135-0"},{"issue":"11","key":"3487_CR23","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1002\/clc.20433","volume":"32","author":"CK Nair","year":"2009","unstructured":"Nair CK et al (2009) Effect of mitral regurgitation on cerebrovascular accidents in patients with atrial fibrillation and left atrial thrombus. Clin Cardiol 32(11):E7\u2013E10","journal-title":"Clin Cardiol"},{"issue":"10","key":"3487_CR24","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/europace\/euw161","volume":"18","author":"A Goette","year":"2016","unstructured":"Goette A et al (2016) EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Europace 18(10):1455\u20131490","journal-title":"Europace"},{"issue":"7","key":"3487_CR25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/jama.2023.27188","volume":"331","author":"H Kamel","year":"2024","unstructured":"Kamel H et al (2024) Apixaban to prevent recurrence after cryptogenic stroke in patients with atrial cardiopathy: the ARCADIA randomized clinical trial. JAMA 331(7):573\u2013581","journal-title":"JAMA"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-025-03487-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-025-03487-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-025-03487-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:32:40Z","timestamp":1784187160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-025-03487-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":25,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["3487"],"URL":"https:\/\/doi.org\/10.1007\/s10554-025-03487-7","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"29 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}